vs
爱德华生命科学（EW）与Liberty Energy Inc.（LBRT）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是Liberty Energy Inc.的1.6倍（$1.6B vs $1.0B），爱德华生命科学净利率更高（23.1% vs 2.2%，领先20.9%），爱德华生命科学同比增速更快（16.7% vs 4.5%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs -6.2%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
Liberty Energy Inc.是北美领先的能源服务供应商，专注为油气运营企业提供水力压裂及完井解决方案，服务覆盖美国主要页岩产区，供应低排放作业设备及定制化支持，帮助提升油气井生产效率。
EW vs LBRT — 直观对比
营收规模更大
EW
是对方的1.6倍
$1.0B
营收增速更快
EW
高出12.2%
4.5%
净利率更高
EW
高出20.9%
2.2%
两年增速更快
EW
近两年复合增速
-6.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.0B |
| 净利润 | $380.7M | $22.6M |
| 毛利率 | 78.0% | — |
| 营业利润率 | 1.8% | 2.2% |
| 净利率 | 23.1% | 2.2% |
| 营收同比 | 16.7% | 4.5% |
| 净利润同比 | 6.8% | 64.8% |
| 每股收益（稀释后） | $0.66 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWLBRT
| Q1 26 | $1.6B | $1.0B | ||
| Q4 25 | $1.6B | $1.0B | ||
| Q3 25 | $1.6B | $947.4M | ||
| Q2 25 | $1.5B | $1.0B | ||
| Q1 25 | $1.4B | $977.5M | ||
| Q4 24 | $1.4B | $943.6M | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.4B | $1.2B |
净利润EWLBRT
| Q1 26 | $380.7M | $22.6M | ||
| Q4 25 | $91.2M | $13.7M | ||
| Q3 25 | $291.1M | $43.1M | ||
| Q2 25 | $333.2M | $71.0M | ||
| Q1 25 | $358.0M | $20.1M | ||
| Q4 24 | $385.6M | $51.9M | ||
| Q3 24 | $3.1B | $73.8M | ||
| Q2 24 | $366.3M | $108.4M |
毛利率EWLBRT
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | 20.6% | ||
| Q3 25 | 77.8% | 18.7% | ||
| Q2 25 | 77.5% | 22.1% | ||
| Q1 25 | 78.7% | 22.1% | ||
| Q4 24 | 78.9% | 21.4% | ||
| Q3 24 | 80.6% | 26.2% | ||
| Q2 24 | 79.9% | 27.9% |
营业利润率EWLBRT
| Q1 26 | 1.8% | 2.2% | ||
| Q4 25 | 9.6% | 1.9% | ||
| Q3 25 | 19.8% | -0.3% | ||
| Q2 25 | 26.8% | 3.6% | ||
| Q1 25 | 27.9% | 1.9% | ||
| Q4 24 | 22.6% | 2.6% | ||
| Q3 24 | 25.9% | 9.4% | ||
| Q2 24 | 26.8% | 12.2% |
净利率EWLBRT
| Q1 26 | 23.1% | 2.2% | ||
| Q4 25 | 5.8% | 1.3% | ||
| Q3 25 | 18.7% | 4.5% | ||
| Q2 25 | 21.7% | 6.8% | ||
| Q1 25 | 25.3% | 2.1% | ||
| Q4 24 | 27.8% | 5.5% | ||
| Q3 24 | 226.7% | 6.5% | ||
| Q2 24 | 26.7% | 9.3% |
每股收益（稀释后）EWLBRT
| Q1 26 | $0.66 | $0.14 | ||
| Q4 25 | $0.16 | $0.08 | ||
| Q3 25 | $0.50 | $0.26 | ||
| Q2 25 | $0.56 | $0.43 | ||
| Q1 25 | $0.61 | $0.12 | ||
| Q4 24 | $0.65 | $0.31 | ||
| Q3 24 | $5.13 | $0.44 | ||
| Q2 24 | $0.61 | $0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $699.1M |
| 总债务越低越好 | — | $7.1M |
| 股东权益账面价值 | — | $1.9B |
| 总资产 | — | $4.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资EWLBRT
| Q1 26 | — | $699.1M | ||
| Q4 25 | $4.2B | $27.6M | ||
| Q3 25 | $3.8B | $13.5M | ||
| Q2 25 | $4.1B | $19.6M | ||
| Q1 25 | $3.9B | $24.1M | ||
| Q4 24 | $4.0B | $20.0M | ||
| Q3 24 | $4.4B | $23.0M | ||
| Q2 24 | $2.0B | $30.0M |
总债务EWLBRT
| Q1 26 | — | $7.1M | ||
| Q4 25 | — | $246.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $190.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益EWLBRT
| Q1 26 | — | $1.9B | ||
| Q4 25 | $10.3B | $2.1B | ||
| Q3 25 | $10.2B | $2.1B | ||
| Q2 25 | $10.5B | $2.0B | ||
| Q1 25 | $10.1B | $2.0B | ||
| Q4 24 | $10.0B | $2.0B | ||
| Q3 24 | $9.5B | $2.0B | ||
| Q2 24 | $7.4B | $1.9B |
总资产EWLBRT
| Q1 26 | — | $4.4B | ||
| Q4 25 | $13.7B | $3.6B | ||
| Q3 25 | $13.3B | $3.5B | ||
| Q2 25 | $13.5B | $3.4B | ||
| Q1 25 | $13.0B | $3.4B | ||
| Q4 24 | $13.1B | $3.3B | ||
| Q3 24 | $13.0B | $3.3B | ||
| Q2 24 | $10.1B | $3.2B |
负债/权益比EWLBRT
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
